Background and Purpose: The aim of the present study, based at Duke University and involving 14 other institutions, is to identify the most appropriate and cost-effective clinical strategies for prevention of ischemic (thrombotic or embolic) stroke in high-risk individuals and to design and test an intervention to disseminate this information to providers and the public.
Stroke is the third leading cause of death in the United States and the leading cause of disability among adults. Every year about 500 000 Americans suffer a stroke, with immense human cost and with financial costs estimated at $25 billion.3 Due to this enormous burden, identification of patients at risk for stroke and prevention of stroke in individuals with elevated risk levels is a high clinical and health policy priority.
Individuals at increased risk for ischemic stroke can be identified by a variety of clinical and behavioral factors. Several general risk factors contribute to the development and progression of atherosclerosis, and these may incite an acute stroke in a susceptible individual. These factors include hypertension,4 cigarette smoking,5-8 hypercholesterolemia,9'10 diabetes mellitus,"1'2 and alcohol consumption. [13] [14] [15] [16] [17] Risk factors more directly associated with ischemic stroke include the presence of cerebrovascular disease and conditions that promote formation of cardiac emboli (such as atrial fibrillation, prosthetic valve, and cardiomyopathy). Patients with asymptomatic carotid bruit (often associated with carotid stenosis) have a stroke risk up to four times that of the general population. [18] [19] [20] [21] [22] prosthetic heart valve, or cardiomyopathy). Based on the results of these efforts, the PORT team will develop recommendations for preventive strategies, disseminate this information, and evaluate the impact of dissemination on physician attitudes and practices. They will use a comprehensive decision model of stroke development and outcome to coordinate these tasks. Hemorrhagic stroke will be considered in the model as a possible complication of treatment, but the model will not address strategies for prevention of hemorrhagic strokes per se.
Objectives
The overall goal of this PORT is to improve health outcomes for persons at risk for stroke by identifying the most appropriate and cost-effective clinical strategies for stroke prevention for high-risk individuals and by designing and testing an intervention to disseminate this information to providers and the public. The spe- 
Scope of the PORT Patient Groups
Four major, stroke-related health conditions, corresponding to four major patient groups, are of interest to the PORT. These conditions, termed "fundamental states," are as follows: (1) having no overt symptoms but at increased risk for cerebrovascular disease (asymptomatic); (2) having had at least one recent TIA; (3) having had at least one stroke with a minor residual deficit (minor stroke); and (4) 
Management Strategies
The primary management strategies considered by the PORT are diagnostic testing and therapeutic interventions. The diagnostic tests of interest are invasive and noninvasive evaluation of the carotid and cerebral circulation (including conventional angiography, various forms of ultrasonography and Doppler scanning, and magnetic resonance angiography), examinations of brain structures (including computed tomography and magnetic resonance imaging), and tests used to characterize embolic risk (including electrocardiography and transthoracic and transesophageal echocardiography). Therapeutic interventions include no action, risk-factor reduction, platelet inhibition, anticoagulation, and carotid endarterectomy.
Outcomes
The primary outcome variables to be considered by the PORT are complication rates, costs, transition probabilities, patient preferences (utilities), and utilization of services. Complication rates are associated with diagnostic and treatment interventions and include both mortality and morbidity. Costs primarily consist of direct medical costs, but indirect costs associated with disability will also be estimated. Transition probabilities describe the probability of changing, over time, from one stroke-related health state to another (for example, the probability of a patient with a TIA having a subsequent major stroke in the following month). Utilities are quantitative representations of patient preferences for health states and interventions. Utilities will be obtained using the time trade-off method (for example, patients will be asked about their willingness to hypofor fewer years of life in perfect health). Utilization will be quantified as number of outpatient visits, length of hospitalization, and use of skilled nursing facilities.
Organizing Structures
Three main organizing structures will be used by this PORT: (1) a taxonomy of patients at elevated stroke risk, (2) a basic model of the natural history of stroke development and outcome and the impact of stroke prevention interventions, and (3) a common data format for all data sources.
To standardize patient-based subgroups, we started with the fundamental patient states classified by cerebrovascular symptom status (asymptomatic but at elevated risk, TIA, minor stroke, and major stroke). These were further subdivided into mutually exclusive and exhaustive subgroups ("expanded states"), based on additional factors (eg, symptomatic patients may be classified by the recency and vascular distribution of symptoms, presence of modifiable risk factors, age, gender, and race). These expanded states represent a compromise between substantive detail and analytical tractability and describe clinically important factors likely to be accurately recorded on all data sources.
The basic stroke model represents stroke risk as having no more than two phases: an early phase (1 month since the defining event) and a late phase. Similarly, the impact of stroke prevention strategies, both in reducing stroke risk and inducing complications, is represented as having both early and late phases. This basic model permits comparison of various data sources and simplifies the formulation of the decision/costeffectiveness model.
Two types of data tables will provide an organizing structure for PORT data. The Evidence Tables will summarize evidence regarding the natural history of disease and the impact of various stroke prevention interventions. One data table will be developed for each outcome. Recommendations for stroke prevention practices will be derived from these tables through the efforts of an expert panel supplemented by the use of a decision cost-effectiveness model. The Variations Table. Areas of discordance will provide the focus for the dissemination effort.
Data Sources
Data sources to be used in the PORT are summarized in Table 1 .
Literature Review
The overall goal of the literature review is to evaluate current information about management strategies for prevention of strokes in high-risk individuals. The five major topic areas to be covered in the literature review include natural history, medical management, surgical management, risk-factor reduction, natural history, and diagnostic testing. For each area, the risks, efficacy, effectiveness, and complications of diagnostic testing and interventions will be considered. In addition, the thetically trade more years of life in their current state In the working groups, physician specialists and methodologists read and review the entire article, make the final inclusion decision, and characterize the research design and results. Articles are read in a hierarchical fashion according to the research design (beginning with randomized controlled trials). Results from the selected studies will be summarized using meta-analyses (when appropriate).32 These, in turn, will be included in the Evidence Tables.
Medicare Claims
Medicare claims files will be used to (1) develop a national profile of patients hospitalized with acute stroke conditions, including medical care costs and utilization; (2) develop a similar national profile of patients hospitalized for carotid endarterectomy; and (3) perform small-area analyses of variations in the use of noninvasive cerebrovascular tests, cerebral angiography, and carotid endarterectomy, controlling for differences in stroke admission rates. For this project, analyses will be limited to individuals at least 65 years of age. ICD-9 diagnostic codes 430 to 438 will be selected for analysis. Data from the Medicare claims files will be used for the Variations Tables and possibly for the  Evidence Tables (if they prove useful for cost analyses).
National profiles of patients admitted with acute stroke and/or carotid endarterectomy will be developed by sampling Medicare hospital claims records for 1991. Prior hospital admissions (1987 through 1990) for the sample will be merged in order to differentiate incident events from recurrent events, and claims from 1992 through 1993 will also be merged to follow longitudinal outcomes. Costs will be contrasted with two comparison groups: Medicare enrollees hospitalized during 1991 and all Medicare enrollees (ie, whether hospitalized or not) during 1991. Costs considered will include those incurred for care at acute care hospitals, rehabilitation facilities, skilled nursing facilities, home health agencies, and hospital outpatient services, as well as charges for physician services, physical/occupational therapy, and durable medical equipment. Small-area analyses will be performed by stratifying metropolitan statistical areas (MSAs) into high-, medium-, and low-stroke incidence areas; by sampling MSAs within these strata; and by describing the pattern of the three stroke prevention interventions within and across strata. Additional Data to Address Cost Direct medical costs will be obtained from two additional sources: United HealthCare Corporation (UHC) and the Academic Medical Centers Consortium (AMCC). UHC will provide all health care claims for individuals under 65 years of age who are served by five geographically dispersed independent practice health plans affiliated with UHC and who have been identified during the period 1989 through 1992 as either asymptomatic at increased stroke risk or symptomatic. Inpatient and outpatient claims will be examined, including physician and pharmacy charges and, for some enrollees, skilled nursing home and other long-term services. AMCC will provide complete inpatient claims on all persons, both over The goal of the national physician survey is to identify physicians' self-reported practices and beliefs about preventing strokes in high-risk individuals. The American Medical Association Masterfile of Physicians will be stratified into general practitioners, family practitioners, internists, neurologists, neurosurgeons, and vascular surgeons. Two thousand surveys, equally distributed across strata, will be obtained. In addition to questions about basic practice information related to treatment of stroke patients and patients at risk of stroke, physicians will be presented with seven patient scenarios ( Table 2 ). For each scenario, possible stroke interventions will be listed (see below), and the physicians will report how often they use or prescribe that intervention for that particular type of patient. The results of the national physician survey will provide information on physician knowledge, attitudes, and practices. These data will be used as evidence for the Variation Tables and for independent analyses as well as for the design of the intervention phase of the PORT. 
National Patient Survey
The goal of the national patient survey is to elicit patient preference (utility), functional status, and quality-of-life information directly from patients. Data will be collected by computer-assisted telephone interviews. Each participant will be asked about utilities for health states using the time/trade-off method.36 Stratification will be according to recruitment site and stroke-related health state (ie, asymptomatic, TIA, and minor stroke only). Patients with major stroke will not be included because we anticipate that participating in a telephone interview would be too burdensome. Because sampling frames are not available to produce nationally representative population-based groups, the sampling is designed to access patients from a variety of health-care delivery sites: the CHS (Forsyth County, North Carolina); five IPA-model health maintenance organization sites of UHC (a nationwide managed-care organization); and five academic medical centers that are members of the AMCC. All subjects in the UHC sample and half of those in the AMCC sample will be under 65 years of age. Subjects recruited from the CHS will be 65 years of age or older. Eligible subjects for the surveys will be identified by sampling at each site from ICD-9 CM diagnostic codes that capture cerebrovascular disease and identify patients with cardioembolic risk factors and major cardiovascular disease.
In-person interviews will be performed for the subsample of patients in the CHS site. For this sample, patients will also be asked about complications and utilities for specific interventions (for example, carotid endarterectomy and use of warfarin). Patient utilities will be entered into the Evidence Tables and Decision Model. Self-reported patient data regarding outcomes, quality of life, and functional status will also be analyzed.
Development of Recommendations
The planned approach takes advantage of the two major methods for developing recommendations: decision modeling and expert "consensus" panels.
Decision/Cost-effectiveness Modeling
The decision/cost-effectiveness model provides estimates of the impact of various stroke-prevention strat-egies. The form of the model is a simulation model based on a previously developed Markov model.37,38 Based on the estimated transition probabilities (the probabilities of moving from one stroke-related state to another), the model projects the natural history of a hypothetical cohort with a given risk profile. The transition probabilities can be modified, reflecting the impact of a specific stroke-prevention strategy in reducing stroke or inducing treatment complications.
The model permits a summary of the impact of various stroke prevention strategies. For example, outputs that can be provided by the model for any intervention applied to any patient group include qualityadjusted life expectancy, cumulative cost, and marginal cost-effectiveness. To calculate quality-adjusted life expectancy and cumulative cost with a simulation model, one must associate an incremental utility and an incremental cost with each stroke-related health state. The incremental utility is the length of time of the model 4"clock cycle (here, 1 day) multiplied by a qualityadjustment factor reflecting the patient's disability level in his or her current state. Incremental costs are those associated with the disability as well as the direct and indirect costs of any medical interventions utilized during the month.
In addition to providing estimates of the relative effectiveness and cost-effectiveness of alternative stroke-prevention strategies, the decision model provides an organizational framework for the Stroke PORT. It serves as a conceptual model of stroke development and prevention so that data from a variety of sources can be interpreted in a straightforward fashion. Moreover, we use the model to focus on collecting those data most likely to improve our ability to make judgments about stroke-prevention interventions and to reduce distractions emanating from secondary questions.
Expert Panels
The recommendations for stroke prevention strategies will be formed primarily by (1) the Evidence and  Variation Tables developed in phases I and III, (2) inferences based on decision and cost-effectiveness analyses, and (3) the judgments of appropriateness and necessity given by a formal expert consensus panel. A panel of experts involved in the care and study of patients at risk for cerebrovascular disease will be assembled to participate in a formal consensus conference. The panel will be provided with the results of our findings from various data sources: literature review, meta-analysis, Medicare claims analysis, primary and secondary data sources, and the decision model. Using the "modified Delphi" approach,39 the expert panel will rate the appropriateness of each stroke-prevention strategy. The recommendations from the different methods will be compared. The scientific advisory panel will resolve any areas of discordance and make the final recommendations.
Dissemination
In phase IV PORT will undertake an interventiondemonstration trial. This trial is designed to ascertain whether the clinical practice recommendations for preventing strokes in high-risk persons (including the evalment of patients thought to be at higher risk of stroke) can be implemented among defined groups of practicing physicians who care for patients with elevated risk for stroke. The rationale for this part of the project is to determine whether these practice recommendations are viewed by physicians as useful and feasible in everyday practice situations. The primary objective of this phase of the project is to measure the extent to which these recommendations have been implemented among the physician practices that are targets of the intervention.
Discussion
In designing a PORT, a central issue is to create organizing structures that are supportive but not restrictive. Because work in an earlier project phase may have profound implications for later phases, a PORT can best be described as work that is "in the process of becoming." A PORT is complex and difficult to administer because it is continually evolving, multiple data sources are being used, and numerous investigators are involved. PORTs must recognize this complexity in the planning stages. In addition, given the breadth of the task, each PORT must focus on the most important questions, the most rigorous methodologies, and the most accessible data sets. In the case of the Stroke PORT, it is crucial for all persons involved to remember the central objective: to identify the most appropriate and cost-effective clinical strategies for stroke prevention.
Since our ultimate goal is to aid the physician in decision making. we have organized the PORT around a decision-making paradigm. The decision/cost-effectiveness model provides a natural design focus for the PORT. It requires that we reveal our beliefs about the process of stroke development and outcome, our estimates of event probabilities, and our judgments about the value of various health outcomes. Each data source is considered primarily as a means of addressing these issues, and each methodological tool is considered a way to provide improved model estimates. Beyond this, the model can suggest preferred management strategies based on decision rules, such as those that seek to maximize expected (average) utility. Whether or not recommendations about preferred stroke prevention strategies are derived directly from the results of decision/cost-effectiveness analysis, the model imposes an organizational discipline for the PORT.
In addition to being a useful organizing principle for the PORT, the decision model has been structured so that it can be used in clinical practice. By identifying the preferred management practices for groups of patients, as well as the factors that most strongly affect decision making, the model will help the physician to better tailor management plans to individual patients. It should be possible to make details of the model available to clinicians in their day-to-day care of patients at increased risk for stroke. This may be done by providing graphical summaries (as has been done for carotid endarterectomy), nomograms, or perhaps interactive versions of the model for general distribution. The model will contain the best available estimates for parameters such as stroke risk and treatment efficacy. These estimates can be updated as new data become available (such as new epidemiological studies and randomized trials), and the model parameters can be uation of symptoms and subsequent clinical managemodified to suit an individual patient.
Despite the various challenges inherent in a PORT, the advantages of the process far outweigh the potential disadvantages. PORTs build upon the strengths of a wide variety of data sources, methodological approaches, and disciplines, all coordinated by a consistent clinical focus. Our research team looks forward to this opportunity to contribute to the technology of PORTs and ultimately to the health of patients at risk for stroke.
